PDL
Watch: the PDL Guide to Medicines by Injection – a risk management perspective
PDL officers discuss key considerations for administration of medicines by injection and share useful new tools and resources What are some of the most common incidents around vaccination or administering …
Mitigating risks of the Opioid Therapy Program
PDL has some advice on common incidents involving the Opioid Therapy Program, following last year’s changes Pharmacists have admirably navigated the changes to the provision of the Opioid Therapy Program …
Administering medicines by injection
PDL offers some timely advice on some of the risks and areas to focus on when administering medicines by injection In recent years, the pharmacy profession has seen significant expansion …
The top 10: PDL practice alerts
Next in our review of 2023, the year’s ten most viewed alerts and advice for pharmacists from PDL Mounjaro update Practising ‘good’ dispensing Focusing on patient privacy Be alert but …
Another variant vaccine, another potential risk
With the availability of the latest Pfizer (Comirnaty) Omicron XBB.1.5 vaccine, indicated for 12 years and over, there may be potential for selection or administration error, writes PDL This is …
Maintaining professional boundaries: A reminder for pharmacists
Meridian Lawyers has collaborated with PDL to prepare an article about professional boundaries and the types of conduct that are likely to be the subject of complaint to regulators. …
Pharmacy Board of Australia registration renewal
Every year, PDL receives calls from pharmacists who have overlooked their Pharmacy Board of Australia (PBA) registration renewal. This may happen due to renewal reminders being quarantined in junk …
WATCH: Risk management processes in pharmacy—compounding and beyond
PDL officers and the MEDISCA CPD coordinator and compounding pharmacist answer your questions on risk management processes in pharmacy During this webinar, Patricia Ullmann from MEDISCA is joined by Gary …
Medicinal cannabis
The prescribing and supply of medicinal cannabis is a rapidly expanding area of practice in Australia With this emerging field comes the need for comprehensive risk management considerations and strategies …
Off-label prescribing: obligations, responsibilities and risk mitigation
PDL has some advice on off-label prescribing and their role in promoting the appropriate and safe use of these medicines Off-label prescribing occurs when a medication is used for a …
Mounjaro update
From single use vials, to explaining off-label prescribing and educating patients on administration, PDL has some advice on Mounjaro In recent weeks, the PDL Professional Officers have received a number …
Reporting culture
A culture focusing on patient safety is essential, and the reporting of errors, near misses and concerns is a critical part of this. PDL has some tips for building a …